Despite guideline recommendations, the use of bioprosthetic heart valves has surpassed mechanical valves, but data from a large surgical database may lead to a reassessment of that practice.

The Medicare data contradict results from the TCW randomized trial but better represent real-world practice, say authors.

Background Aortic stenosis is a degenerative condition with high mortality in its severe stages and no preventive treatment.

New Delhi: Global medical device maker Abbott has introduced the Navitor Vision in India, a state-of-the-art valve technology for treating symptomatic severe aortic stenosis in patients who face ...

All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...

to be considered as a bridge to surgical aortic valve replacement or to transcatheter intervention in haemodynamically unstable patients and in those with aortic stenosis (AS) who require urgent ...

The left heart pump consists of the left atrium, mitral valve, left ventricle, aortic valve, and aorta. Its job is to pump oxygen-rich blood out to the body’s tissues. Blood returning to the heart ...

and aortic stenosis, or narrowing of the aortic valve. Nonsyndromic means that the condition is not part of another syndrome. Research has shown that duplications or deletions of genomic DNA in ...

The coexistence of transthyretin cardiac amyloidosis (ATTR‐CA) and aortic stenosis (AS) is increasingly recognized, but the clinical consequences are unclear. We aimed to characterize clinical ...

Aortic stenosis (AS) was historically considered a disease of the ... the AS patients who are at increased risk of adverse clinical outcomes after aortic valve replacement (AVR). It is now ...

Whether transcatheter aortic-valve replacement can improve outcomes in patients with asymptomatic severe aortic stenosis has been unclear. New research findings comparing TAVR with clinical ...